Phase 3, single‐arm, multicenter study of dabigatran etexilate for secondary prevention of venous thromboembolism in children: Rationale and design

BACKGROUND: Anticoagulant therapy for venous thromboembolism (VTE) in children is largely based on treatment recommendations for adults. However, differences in both physiology (ie, renal maturation and drug excretion) and developmental hemostasis must be considered when treating children, as such d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Res Pract Thromb Haemost
Autors principals: Luciani, Matteo, Albisetti, Manuela, Biss, Branislav, Bomgaars, Lisa, Brueckmann, Martina, Chalmers, Elizabeth, Gropper, Savion, Halton, Jacqueline M. L., Harper, Ruth, Huang, Fenglei, Manastirski, Ivan, Mitchell, Lesley G., Tartakovsky, Igor, Wang, Bushi, Brandão, Leonardo R.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Online‐only Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6046601/
https://ncbi.nlm.nih.gov/pubmed/30046763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12093
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars